Cellectis Statistics

Total Valuation

Cellectis has a market cap or net worth of EUR 93.11 million. The enterprise value is 64.05 million.

Market Cap	93.11M
Enterprise Value	64.05M

Important Dates

The next estimated earnings date is Monday, August 4, 2025.

Earnings Date	Aug 4, 2025
Ex-Dividend Date	n/a

Share Statistics

Cellectis has 72.29 million shares outstanding. The number of shares has increased by 57.25% in one year.

Current Share Class	72.29M
Shares Outstanding	72.29M
Shares Change (YoY)	+57.25%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	2.20%
Owned by Institutions (%)	16.95%
Float	38.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.84
PB Ratio	0.87
P/TBV Ratio	0.87
P/FCF Ratio	3.81
P/OCF Ratio	3.45
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.14
EV / Sales	1.26
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	2.62

Financial Position

The company has a current ratio of 1.67, with a Debt / Equity ratio of 0.83.

Current Ratio	1.67
Quick Ratio	0.94
Debt / Equity	0.83
Debt / EBITDA	n/a
Debt / FCF	3.65
Interest Coverage	-7.09

Financial Efficiency

Return on equity (ROE) is -58.55% and return on invested capital (ROIC) is -16.23%.

Return on Equity (ROE)	-58.55%
Return on Assets (ROA)	-9.19%
Return on Invested Capital (ROIC)	-16.23%
Return on Capital Employed (ROCE)	-26.22%
Revenue Per Employee	231,287
Profits Per Employee	-255,727
Employee Count	222
Asset Turnover	0.15
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -46.31% in the last 52 weeks. The beta is 3.20, so Cellectis's price volatility has been higher than the market average.

Beta (5Y)	3.20
52-Week Price Change	-46.31%
50-Day Moving Average	1.33
200-Day Moving Average	1.60
Relative Strength Index (RSI)	41.26
Average Volume (20 Days)	70,803

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cellectis had revenue of EUR 50.65 million and -56.00 million in losses. Loss per share was -0.57.

Revenue	50.65M
Gross Profit	50.65M
Operating Income	-48.89M
Pretax Income	-55.76M
Net Income	-56.00M
EBITDA	-37.98M
EBIT	-48.89M
Loss Per Share	-0.57

Full Income Statement

Balance Sheet

The company has 118.09 million in cash and 89.03 million in debt, giving a net cash position of 29.06 million or 0.40 per share.

Cash & Cash Equivalents	118.09M
Total Debt	89.03M
Net Cash	29.06M
Net Cash Per Share	0.40
Equity (Book Value)	107.51M
Book Value Per Share	1.49
Working Capital	101.08M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 26.96 million and capital expenditures -2.55 million, giving a free cash flow of 24.41 million.

Operating Cash Flow	26.96M
Capital Expenditures	-2.55M
Free Cash Flow	24.41M
FCF Per Share	0.34

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -96.52% and -110.57%.

Gross Margin	100.00%
Operating Margin	-96.52%
Pretax Margin	-110.09%
Profit Margin	-110.57%
EBITDA Margin	-74.98%
EBIT Margin	-96.52%
FCF Margin	48.19%

Dividends & Yields

Cellectis does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-57.25%
Shareholder Yield	n/a
Earnings Yield	-60.15%
FCF Yield	26.22%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cellectis has an Altman Z-Score of -0.95. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.95
Piotroski F-Score	n/a